As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Switching off a single enzyme in immune cells protected mice from obesity, type 2 diabetes, and fatty liver disease in a new study, offering a potential new treatment target for metabolic disorders.

Is Obesity Genetic or Environmental? Get All the Details This article was reviewed by Lynn Marie Morski, MD, JD. Key ...

A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or ...

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the pharmacologic treatment of obesity and overweight in adults.

The prevalence of type 2 diabetes and obesity worldwide is increasing, and these two conditions have a bidirectional and linear relationship. Obesity worsens the development of type 2 diabetes by ...

Get a load of this — you may be obese after all! About 40% of US adults — more than 100 million Americans — are considered obese. It’s a growing public health crisis that makes patients vulnerable to ...

WASHINGTON — The size of your gut may be partly shaped by which microbes call it home, according to new research linking obesity to types of digestive bacteria. Both obese mice — and people — had more ...